Johnny MahlanguVíctor Jimenez-YusteGiuliana VentrigliaMarkus NiggliSimona BarleraE et al2024-10-182024-10-18WOS2475-0379https://hdl.handle.net/10539/41703Long term outcomes with emicizumab in hemophilia A without inhibitors result from HAVEN 3 and 4 studiesJournal Article